Clinton Health Access Initiative (CHAI) and Global Health Labs

Clinton Health Access Initiative (CHAI): Boston, Massachusetts, USA Global Health Labs: Bellevue, Washington, USA All United States companies → — Founded Clinton Health Access Initiative (CHAI): 2002 Global Health Labs: 2020

AI Research Lab Point-of-Care Diagnostics Specialty-Focused AI

Obstetrics & Gynecology Oncology Radiology

OB/GYN AI Oncology AI Radiology & Imaging AI

Clinton Health Access Initiative (CHAI): Primarily funded by philanthropic foundations, multilateral organizations, and high-income country governments. Receives grants from organizations like the Bill & Melinda Gates Foundation. Global Health Labs: Joined the Gates Foundation.

Website Claim this company

Products

Automated Visual Evaluation (AVE)

Clinton Health Access Initiative (CHAI) and Global Health Labs

OB/GYN AI

Automated Visual Evaluation (AVE) is an AI model developed by CHAI and Global Health Labs to detect precancerous cervical lesions from smartphone images, outperforming standard visual inspection methods and intended for use in cervical cancer screening.

Not available publicly

See all 1 product →

About Clinton Health Access Initiative (CHAI) and Global Health Labs

The Clinton Health Access Initiative (CHAI) is a global health organization established in 2002 by President Bill Clinton. Its foundational mission was to address the HIV/AIDS epidemic by making life-saving drugs accessible and affordable in low- and middle-income countries. Over the years, CHAI has expanded its scope to tackle a broader range of global health challenges, including malaria, tuberculosis, hepatitis, maternal and child health, and non-communicable diseases like cancer, diabetes, and hypertension. CHAI operates by working with governments and the private sector to strengthen health systems, negotiate lower prices for essential medicines and diagnostics, and implement evidence-based programs to improve healthcare delivery and outcomes.

CHAI’s approach involves acting as a market shaper to drive down the cost of health commodities, serving as a trusted strategic partner to help develop robust health policies, and functioning as an operational partner to translate these policies into actionable programs. The organization emphasizes sustainability, aiming for government-led solutions and programs designed for national scale-up and replication in other countries. CHAI’s work has significantly impacted global health by reducing the cost of HIV/AIDS drugs, expanding access to malaria prevention and treatment, and improving maternal and child health services, ultimately saving millions of lives.

Global Health Labs (GHL) is an organization that builds tools and technologies to address unmet needs in primary healthcare centers and last-mile service delivery in low- and middle-income countries. GHL’s focus includes developing innovative solutions for cold chain and last-mile challenges, as well as new tools for the diagnosis, surveillance, and treatment of diseases disproportionately affecting these regions. Global Health Labs has recently joined the Gates Foundation, which is expected to enhance its ability to develop, manufacture, and distribute healthcare innovations and tools globally, particularly in areas like diagnostics, primary healthcare, and maternal and newborn health.

Focus Areas

Clinton Health Access Initiative (CHAI): HIV/AIDS Malaria Tuberculosis Hepatitis Cancer Non-Communicable Diseases (NCDs) including diabetes hypertension and sickle cell disease Maternal and Child Health (including maternal newborn and reproductive health diarrhea pneumonia and nutrition) Vaccines Health Workforce and Financing Assistive Technologies for Disabilities Digital Health and the intersection of Climate and Health. Global Health Labs: Developing tools and technologies for primary healthcare centers and last-mile service delivery in low- and middle-income countries with a focus on cold chain and last-mile challenges and new tools for diagnosis surveillance and treatment of diseases.

What Physicians Need to Know

HIV/AIDS

CHAI has been instrumental in dramatically reducing the cost of HIV/AIDS treatment, from over US$10,000 per person per year to less than US$45 per adult per year and under US$100 per child per year, making best-in-class treatment accessible to over 28 million people in low- and middle-income countries. They have also accelerated the development and approval of generic HIV drugs, such as pediatric DTG, now available in over 90 countries.

Malaria

CHAI supports national malaria programs by strengthening disease surveillance, improving case management, and increasing access to diagnostic testing and treatment. Their efforts have led to significant declines in malaria cases in supported regions, including a 74% decline in Central America and a 77% decline in the Greater Mekong between 2015 and 2020. They also work on strengthening entomological data capacity to inform vector control strategies.

Tuberculosis

CHAI works to eliminate TB by helping governments identify, diagnose, treat, and prevent the disease. They facilitate the introduction of new, quality-assured products at lower prices, offering higher cure rates and shorter treatment durations. A notable initiative includes a US$15 million project in India to prevent TB spread among children under five, focusing on community-based household contact management and reducing drug costs.

Hepatitis

CHAI has significantly reduced the cost of hepatitis C treatment, achieving an 81% to 97% price reduction, making a cure as low as US$60 per patient. They support governments in initiating public HCV programs, simplifying patient care models, and leveraging existing HIV and maternal health infrastructure for HBV diagnosis and treatment.

Cancer

CHAI's programs in Non-Communicable Diseases include a focus on cancer, particularly cervical cancer, aiming to expand access to diagnosis and treatment in low- and middle-income countries.

Non-Communicable Diseases (NCDs)

CHAI addresses NCDs like diabetes, hypertension, and sickle cell disease by taking a holistic approach to increase access to diagnosis, treatment, and continuous care. They work with governments to create sustainable plans, improve data collection, and ensure access to essential commodities.

Maternal and Child Health

CHAI has an integrated strategy to reduce maternal and neonatal deaths, stillbirths, and unintended pregnancies. They focus on improving access to reproductive health education, contraceptive methods, critical vaccines, and combating chronic malnutrition. Their work has shown significant reductions in maternal and neonatal mortality in regions like Zambia.

Vaccines

CHAI works to improve vaccine affordability and supply security, enhance cold chain and logistics systems, and strengthen national immunization programs. They have negotiated significant price reductions for various vaccines, such as a 67% reduction for rotavirus vaccine and a 56% reduction for inactivated polio vaccine.

Health Workforce and Financing

CHAI strengthens health systems by working with governments to improve health financing and workforce capabilities. They provide technical assistance, support training of health professionals, and help establish sustainable health systems.

Assistive Technologies for Disabilities

CHAI collaborates with governments and partners to integrate assistive technology into public sectors, aiming to improve accessibility and affordability of products like wheelchairs, hearing aids, and eyeglasses. They support policy development, procurement guidelines, and market-oriented interventions.

Digital Health

CHAI supports digital health initiatives to strengthen health systems, including the development of digital surveillance tools for diseases like malaria.

Climate and Health

Recognizing the health risks of climate change, CHAI is engaging in initiatives like the Clean Cooling program to avert CO2 emissions, mitigate extreme heat, and save energy costs. They also help public health programs understand and mitigate the effects of climate change on disease reduction and life-saving efforts.

Global Health Labs (GHL) - Tools & Technologies

Global Health Labs (now part of the Gates Foundation) specializes in developing tools and technologies for primary healthcare centers and last-mile service delivery in low- and middle-income countries. Their focus areas include cold chain and last-mile challenges, and new tools for diagnosis, surveillance, and treatment of diseases.

Global Health Labs (GHL) - Cold Chain & Last-Mile Delivery

GHL focuses on innovative solutions for cold chain and last-mile challenges, which are crucial for delivering temperature-sensitive medical products like vaccines to remote areas.

Physician Tip

For physicians working in low- and middle-income countries, CHAI and Global Health Labs offer crucial support by: n* **Improving Access to Affordable Diagnostics and Treatments:** CHAI's market-shaping efforts directly translate to lower costs for essential medicines and diagnostics across various disease areas, making treatments more accessible to patients. n* **Strengthening Health Systems:** Their work with governments helps build more robust and sustainable health systems, leading to better infrastructure, supply chains, and trained health workforces. n* **Providing Innovative Tools for Primary Care:** Global Health Labs' focus on developing technologies for primary healthcare centers and last-mile delivery can equip physicians with better diagnostic, surveillance, and treatment tools, especially in remote settings. n* **Enhancing Disease Surveillance and Data-Driven Interventions:** CHAI's support in strengthening disease surveillance and data analysis allows for more targeted and effective interventions, improving patient outcomes. n* **Facilitating Access to Assistive Technologies:** For patients with disabilities, CHAI's work in making assistive technologies more affordable and available can significantly improve quality of life and participation in society.

CHAI and Global Health Labs primarily operate through partnerships with governments, local health ministries, and other global health organizations. Their 'technology stack' is less about proprietary software platforms for direct physician use and more about: n* **Market Shaping and Procurement Systems:** Leveraging business expertise to negotiate lower prices for health commodities and improve supply chain efficiency. n* **Data Systems and Analytics:** Supporting the development and implementation of data systems for disease surveillance, program monitoring, and evidence-based policy making. n* **Cold Chain and Logistics Solutions:** Global Health Labs specifically focuses on developing and implementing technologies to address cold chain and last-mile delivery challenges for sensitive medical products. n* **Training and Capacity Building Frameworks:** Providing technical assistance and training programs to strengthen local health workforces and government capabilities. nnDirect integrations for individual physicians would likely occur at the national or local health system level, where CHAI and GHL's interventions are implemented to improve overall healthcare delivery and access to resources.

At a glance

Founded Clinton Health Access Initiative (CHAI): 2002 Global Health Labs: 2020

HQ Clinton Health Access Initiative (CHAI): Boston, Massachusetts, USA Global Health Labs: Bellevue, Washington, USA · United States

CEO Clinton Health Access Initiative (CHAI): Dr. Neil Buddy Shah Global Health Labs: Unknown

Funding Clinton Health Access Initiative (CHAI): Primarily funded by philanthropic foundations, multilateral organizations, and high-income country governments. Receives grants from organizations like the Bill & Melinda Gates Foundation. Global Health Labs: Joined the Gates Foundation.

Products 1

Visit site

Products by Clinton Health Access Initiative (CHAI) and Global Health Labs

1 product in the directory

Automated Visual Evaluation (AVE)

Clinton Health Access Initiative (CHAI) and Global Health Labs

OB/GYN AI

Not available publicly

What the Web Says

The Clinton Health Access Initiative (CHAI) and Global Health Labs generally receive positive reviews as employers, with a strong emphasis on their mission-driven work in global health. Employees often highlight the supportive environment, opportunities for learning, and the meaningful nature of the work. However, some areas for improvement include job security, compensation, and management effectiveness. There were no specific product reviews found for either organization.

Overall: Positive

Strengths

Mission-driven and meaningful work in global health.
Supportive and inclusive work environment.
Opportunities for learning and professional growth.
Good work-life balance reported by some employees.
Competitive salary and benefits for an NGO.
Flexible working environment.

Limitations

Job security can be an issue due to project-based contracts.
Compensation and benefits could be higher for the workload according to some.
Management effectiveness and leadership sometimes need improvement.
Heavy workload and long hours reported by some.
Lack of diversity mentioned in one review.
Internal drama and unorganized processes.

Based on reviews from: Comparably, Indeed.com, Quora, Job365.ai

Last updated: 2026-09-30

Videos

News, demos, and interviews about Clinton Health Access Initiative (CHAI) and Global Health Labs.

Loading videos...

Videos load interactively. If none appear, search YouTube for Clinton Health Access Initiative (CHAI) and Global Health Labs →

View all on YouTube

No press coverage or publications on file yet. Know of some? Suggest an edit →

Frequently Asked Questions

What specific diseases and health areas does the Clinton Health Access Initiative (CHAI) focus on?

CHAI focuses on a wide range of health issues, including infectious diseases like HIV/AIDS, Malaria, Tuberculosis, and Hepatitis. They also address Non-Communicable Diseases (NCDs) such as cancer, diabetes, hypertension, and sickle cell disease, as well as Maternal and Child Health, vaccines, health workforce and financing, assistive technologies for disabilities, digital health, and the intersection of climate and health.

How does CHAI work to reduce the cost of treatments and improve access to healthcare in low- and middle-income countries?

CHAI acts as a market shaper by negotiating with manufacturers to lower the prices of essential health products, such as HIV, Hepatitis B and C, and sickle cell disease treatments. They also work with governments to strengthen national health systems, develop sustainable financing solutions, and improve supply chains to ensure these affordable products reach those in need.

What is the role of Global Health Labs (GHL) and how does it complement CHAI's mission?

Global Health Labs (GHL) develops tools and technologies specifically for primary healthcare centers and last-mile service delivery in low- and middle-income countries. Their focus includes innovations for cold chain and last-mile challenges, as well as new tools for diagnosis, surveillance, and treatment of diseases, which complements CHAI's efforts to improve access to healthcare by providing appropriate technologies.

What kind of partnerships does CHAI engage in to achieve its goals?

CHAI partners with governments, donors, and other key stakeholders to implement its programs. They also collaborate with generic manufacturers to secure lower prices for drugs and diagnostics. Additionally, CHAI works with organizations like the National Association of Community Health Centers (NACHC) to help safety-net providers adopt artificial intelligence responsibly.

How does CHAI address compliance and ethical considerations, especially concerning new technologies like AI?

The Coalition for Health AI (CHAI) is dedicated to advancing the responsible development, deployment, and oversight of AI in healthcare. They work to establish voluntary, widely endorsed standards for AI use in clinical settings, emphasizing transparency, equity, patient safety, and bias mitigation. CHAI also collaborates with organizations like the Joint Commission to develop guidance for deploying AI tools in healthcare.

What is the organizational stability and funding model for CHAI and Global Health Labs?

The Clinton Health Access Initiative (CHAI) is a non-profit organization that secures funding through various investors and partnerships. Global Health Labs (GHL) was a non-profit organization fully funded by Gates Ventures and has since joined the Gates Foundation to enhance its ability to develop and distribute healthcare innovations.

How does CHAI support health workforce development and health financing in partner countries?

CHAI works with governments to strengthen national financing systems, including establishing national health insurance plans. They also help develop systems to educate healthcare professionals at all levels and build the necessary physical infrastructure to deliver health services.

Related Companies

Suggest an Edit → | Report an issue